Full Framework Edges Closer
February 19, 2026
Policy • Innovation • Growth
France Extends Medical Cannabis Access Again – Patients To Continue Receiving Treatment
Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated full generalised framework edges towards reality.
France’s Ministry of Health announced yesterday that patients currently enrolled in the country’s long-running medical cannabis programme will receive another extension beyond the March 31, 2026 deadline, though exactly how long this latest extension will last is unclear.
While this is a critical move by the French government, it fails to address the wider issue of inaction regarding the country’s incoming generalised framework.
State of Play: France 🇫🇷
As France’s medical cannabis pilot program reached a critical juncture, this session provided vital insights into France’s evolving regulatory landscape. Panelists analysed the latest pilot program progress, examined patient access challenges, prescriber engagement, and supply chain hurdles.
France: Medical Cannabis
Market Forecasts 2027-2029
Market Size
Expected market size by 2029, up from €3.3M in 2027
2027: €3.3M | 2028: €4.1M | 2029: €17.9M
Source: Prohibition Partners, 2025
Patient Population
Projected patients by 2029, up from 5,454 in 2027
2027: 5,454 | 2028: 8,626 | 2029: 28,312
Source: Prohibition Partners, 2025
Prices Rise on
5 February 2026
An unmissable date for your 2026 events calendar
The Businesses Behind
The Future
Our sponsors and exhibitors include the global cannabis pioneers and Europe’s established industry leaders — showcasing the partnerships, science, and capital fuelling sustainable growth across the European market.
A limited number of sponsorship opportunities remain. Sponsorship applications close on 31 January 2026.
Apply to Sponsor ➜
